IRIS
COLUSSI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.475
EU - Europa 3.647
AS - Asia 2.814
SA - Sud America 463
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 4
Totale 17.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.392
SG - Singapore 1.143
UA - Ucraina 1.114
IT - Italia 798
CN - Cina 728
HK - Hong Kong 542
DE - Germania 537
BR - Brasile 428
FI - Finlandia 374
RU - Federazione Russa 272
IE - Irlanda 195
TR - Turchia 125
SE - Svezia 113
GB - Regno Unito 71
KR - Corea 70
CA - Canada 59
VN - Vietnam 58
FR - Francia 51
IN - India 31
BD - Bangladesh 23
BE - Belgio 23
AT - Austria 21
EU - Europa 19
IQ - Iraq 17
IR - Iran 16
AR - Argentina 15
MX - Messico 15
NL - Olanda 15
CZ - Repubblica Ceca 14
JP - Giappone 9
PK - Pakistan 9
PL - Polonia 9
ES - Italia 8
ZA - Sudafrica 8
JO - Giordania 6
EG - Egitto 5
MA - Marocco 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CO - Colombia 4
EE - Estonia 4
TN - Tunisia 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
HN - Honduras 3
KE - Kenya 3
LB - Libano 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
TG - Togo 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BT - Bhutan 2
DZ - Algeria 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
ME - Montenegro 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.455
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.428
Fairfield 1.110
Ann Arbor 912
Jacksonville 796
Chandler 594
Houston 574
Hong Kong 542
Ashburn 538
Singapore 531
Dearborn 501
Wilmington 495
Seattle 453
Cambridge 370
Beijing 360
Boardman 282
Princeton 217
Dublin 193
Udine 150
Izmir 107
Hefei 90
San Diego 83
Seoul 60
Munich 49
Des Moines 48
Ogden 48
Dong Ket 47
Norwalk 44
Redmond 42
Milan 40
Ottawa 40
Nanjing 37
Rome 32
San Mateo 32
Kunming 30
São Paulo 28
Los Angeles 26
Guangzhou 25
Nuremberg 25
Helsinki 24
Brussels 23
New York 20
Trieste 19
Santa Clara 16
Belo Horizonte 15
San Francisco 14
Shanghai 14
Mcallen 13
Phoenix 13
Vienna 13
Brno 12
Grafing 12
Falls Church 11
Turku 11
Washington 11
Brooklyn 10
Goiânia 10
Jinan 10
London 10
Rio de Janeiro 10
Baghdad 9
Bologna 9
Boston 9
Düsseldorf 9
Fuzhou 9
Pignone 9
Turin 9
Vicenza 9
Council Bluffs 8
Espoo 8
Frankfurt am Main 8
Indiana 8
Wuhan 8
Ferrara 7
Tokyo 7
Warsaw 7
Ankara 6
Chicago 6
Hangzhou 6
Hebei 6
Leawood 6
Mumbai 6
Nanchang 6
Porto Alegre 6
Tavagnacco 6
Torre Del Greco 6
Zhengzhou 6
Amman 5
Ancona 5
Castellammare Di Stabia 5
Changsha 5
Charlotte 5
Chennai 5
Dallas 5
Dhaka 5
Henderson 5
Ho Chi Minh City 5
Johannesburg 5
Manchester 5
Palermo 5
Paris 5
Totale 11.539
Salva come PNG Salva come JPEG
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 245
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 178
Aldosterone and the heart: from basic research to clinical evidence 162
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 158
Aldosterone and Left Ventricular Remodeling 156
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 146
Aldosterone and the heart: still an unresolved issue? 138
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 138
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 137
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 137
Aldosterone, Organ Damage, and Dietary Salt 137
The emergent cardiovascular risk factors and organ damage in arterial hypertension 136
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 134
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 133
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 132
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 130
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 130
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 128
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 128
Treatment of primary aldosteronism and organ protection 128
Benzodiazepines: an old class of new antihypertensive drugs? 127
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 127
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 125
Kidney in primary aldosteronism: a key determinant of treatment outcome 123
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 122
Renal function in primary aldosteronism 121
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 121
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 121
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 120
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 120
Salt, hypertension, and cardiovascular disease 119
Cardiovascular outcomes in patients with primary aldosteronism after treatment 118
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 117
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 117
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 116
Potassium-sparing diuretics in hypertension 115
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 115
Diabetes, diabetic complications, and blood pressure targets 114
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 113
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 112
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 112
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 112
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 111
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 111
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 111
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 109
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 108
Hypertension and type 2 diabetes: lights and shadows about causality 108
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 104
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 104
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 104
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 104
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 104
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 102
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 102
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 102
Uricaemia and left ventricular mass in hypertensive patients 102
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 102
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 101
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 101
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 100
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 100
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 100
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 99
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 98
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 98
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 97
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 97
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 94
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 94
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 94
Hyperaldosteronism and Left Ventricular Hypertrophy 94
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 94
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 94
Renal function in primary aldosteronism: revisiting the concept of “renin escape” 94
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 93
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 92
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 91
Cardiac and renal damage in primary aldosteronism 90
Effects of renal revascularization on renal and cardiac function in hypertensive patients 89
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 89
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 89
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 89
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 87
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 86
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism 85
Reversal of left ventricular hypertrophy after treatment is related to severity of disease in patients with primary aldosteronism 84
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 84
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 84
Metabolic Dysfunction in Primary Aldosteronism 83
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 82
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 82
Long-term out come of renal cysts in patients with primary aldosteronism 81
Plasma aldosterone levels are related to urinary albumin excretion in hypertensive patients 81
Renal and cardiovascular outcomes in renal revascularization in patients with resistant hypertension. 80
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study 80
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 80
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 79
Endothelial function in patients with non-alcoholic fatty liver disease 79
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 79
Totale 10.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.441 69 243 68 315 79 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20253.580 80 265 141 116 72 155 173 186 415 294 638 1.045
2025/2026243 243 0 0 0 0 0 0 0 0 0 0 0
Totale 18.038